This understanding may indicate that a reduction in the expression of MMP-2 and MMP-9 after bariatric surgery could be a marker of clinical improvement in obesity, since a reduction in serum MMP levels is associated with a control of extracellular matrix function in adipocytes. The gene discussed is MMP2; the disease is obesity due to melanocortin 4 receptor deficiency.